Omi/HtrA2 Mulan E3 ubiquitin ligase Apoptosis mnd2 mouse Oxidative stress Mitophagy Omi/HtrA2 is a nuclear encoded mitochondrial serine protease with dual and opposite functions that depend entirely on its subcellular localization. During apoptosis, Omi/HtrA2 is released into the cytoplasm where it participates in cell death. While confined in the inter-membrane space of the mitochondria, Omi/HtrA2 has a pro-survival function that may involve the regulation of protein quality control (PQC) and mitochondrial homeostasis. Loss of Omi/HtrA2's protease activity causes the neuromuscular disorder of the mnd2 (motor neuron degeneration 2) mutant mice. These mice develop multiple defects including neurodegeneration with parkinsonian features. Loss of Omi/HtrA2 in non-neuronal tissues has also been shown to cause premature aging. The normal function of Omi/HtrA2 in the mitochondria and how its deregulation causes neurodegeneration or premature aging are unknown. Here we report that the mitochondrial Mulan E3 ubiquitin ligase is a specific substrate of Omi/HtrA2. During exposure to H 2 O 2 , Omi/HtrA2 degrades Mulan, and this regulation is lost in cells that carry the inactive protease. Furthermore, we show accumulation of Mulan protein in various tissues of mnd2 mice as well as in Omi/HtrA2(−/−) mouse embryonic fibroblasts (MEFs). This causes a significant decrease of mitofusin 2 (Mfn2) protein, and increased mitophagy. Our work describes a new stress-signaling pathway that is initiated in the mitochondria and involves the regulation of Mulan by Omi/HtrA2 protease. Deregulation of this pathway, as it occurs in mnd2 mutant mice, causes mitochondrial dysfunction and mitophagy, and could be responsible for the motor neuron disease and the premature aging phenotype observed in these animals.
Introduction
It is now well established that oxidative stress, mitochondrial dysfunction, and deregulation of the ubiquitin-proteasome system (UPS) underlie selective neuronal cell death and can lead to neurodegenerative disorders such as Parkinson's disease (PD) [1] [2] [3] . Our studies have focused on the mitochondrial serine protease Omi/HtrA2, originally isolated in our laboratory, which participates in apoptosis as well as in mitochondrial homeostasis [4] [5] [6] . The role of Omi/HtrA2 in cell death has been well documented, reviewed in [7] [8] [9] . Permeabilization of the outer mitochondrial membrane upon induction of apoptosis allows the release of Omi/HtrA2 from the inter-membrane space (IMS) to the cytoplasm, where it participates in both caspase-dependent as well as caspase-independent cell death [10] [11] [12] [13] . However, under normal conditions Omi/HtrA2 is restricted to the IMS where it performs a pro-survival function that remains uncharacterized. The notion of a pro-survival role of Omi/HtrA2 in the IMS arises from the neurodegenerative phenotype of the Omi/HtrA2 knockout mice that have a targeted deletion of the whole gene [14] . The same phenotype is also found in the mnd2 mutant mice, caused by a missense mutation that affects the protease activity of Omi/HtrA2 [15] . In addition to neurodegeneration, these mutant mice show a plethora of defects including small size, muscular degeneration, and atrophy in various organs such as the heart, kidney, thymus, and spleen [14] . Furthermore, loss of Omi/HtrA2 activity in non-neuronal tissues has recently been shown to cause premature aging [16, 17] . In addition to the effects of Omi/HtrA2 in mouse models, several human studies linked Omi/HtrA2 deregulation to neurodegenerative diseases. Point mutations in Omi/HtrA2 gene have been detected in patients with Parkinson's disease, and Omi/HtrA2 (PARK13) was identified as a susceptibility factor for PD [18] [19] [20] . Since the protease activity of Omi/HtrA2 is necessary and essential for its pro-survival function, it suggests that the cleavage of specific substrates is involved. Mitochondrial Omi/HtrA2 has been shown to cleave the anti-apoptotic protein Hax-1, Parkin, Presenilin-1, amyloid precursor protein, Parl (presenilin-associated, rhomboid-like), and the mitochondrial fusion factor OPA1 [21] [22] [23] [24] [25] [26] . Collectively, these reports strongly support the notion that mitochondrial Omi/HtrA2 has a neuroprotective function.
Here we identified Mulan (Mitochondrial Ubiquitin Ligase Activator of NF-kB) [27] also known as GIDE (Growth Inhibition and Death E3 Ligase) [28] or Hades [29] , to be a specific substrate of Omi/HtrA2 protease. Mulan is localized in the outer mitochondrial membrane (OMM) and has a domain exposed in the IMS and a RING-finger domain facing the cytoplasm [27, 28] . We show that Mulan protein levels are tightly regulated by Omi/HtrA2 protease under normal conditions, during oxidative stress, or after treatment with the mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP). In addition, we observed accumulation of the Mulan protein in the tissues of mnd2 mutant mice that lack an active Omi/HtrA2 protease. Furthermore, we found that upregulation of Mulan, in the absence of Omi/HtrA2, leads to the degradation and removal of Mfn2 protein. Mfn2 downregulation by Mulan ligase has previously been shown to induce mitochondrial dysfunction and mitophagy in muscle cells [30, 31] . Our studies clearly show that the absence of Omi/HtrA2 protease leads to increased mitophagy in MEFs under normal conditions or after treatment with CCCP. This is the first report of a direct link between mitochondrial Omi/HtrA2, Mulan E3 ubiquitin ligase and mitophagy. This mechanism defines a new function of Omi/HtrA2 in mitochondrial homeostasis. Furthermore, it suggests how the absence of Omi/HtrA2 or its inactivation can lead to mitochondrial dysfunction and mitophagy, resulting in neuronal cell death, premature aging, and the overall phenotype observed in the mnd2 mutant mice.
Materials and methods
2.1. Cell culture HEK293 and HK-2 (human kidney-2: renal proximal tubular epithelial cells) were obtained from ATCC, and cultured in DMEM containing 10% fetal bovine serum, 50 units/ml of penicillin and 50 μg/ml of streptomycin [22] . Omi/HtrA2 mouse embryonic fibroblasts (MEFs) were derived from Omi/HtrA2 knockout mice [14] . Omi/HtrA2(−/−), Omi/HtrA2(+/+) and Omi/HtrA2-S/A MEFs were generated by stably transfecting the MSCV vector alone (−/−), MSCV-Omi/HtrA2(+/+) or MSCV-Omi/HtrA2-S/A (Ser306Ala). All three cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 units/ml of penicillin, 50 μg/ml of streptomycin and 0.5 μg/ml of puromycin. Oxidative stress was induced using 50 μM of H 2 O 2 for 10 h. These conditions have been previously shown to induce optimal stress in Omi/HtrA2(−/−) and Omi/HtrA2(+/+) MEFs [14, 25] .
Antibodies, chemicals and Western blot analysis
Antibodies used in our study include: Mulan polyclonal (Novus Biologicals), Omi/HtrA2 rabbit polyclonal [22, 32] , March5 polyclonal (Aviva Systems Biology), RNF185 polyclonal (Genetex), cytochrome c monoclonal (R&D Systems), Mfn2 monoclonal (Santa Cruz Biotechnology), GAPDH and β-actin monoclonal antibodies (Sigma). Secondary peroxidase-conjugated goat anti-rabbit, goat anti-mouse or donkey anti-goat antibodies were from Jackson ImmunoResearch Laboratories. Non-potentiometric MitoTracker Red 580 and MitoTracker Green were used as recommended [33] . MitoTracker dyes, MitoSOX, and LysoTracker Red were from Molecular Probe. H 2 O 2 , etoposide, cisplatin, antimycin, paraquat and CCCP were all purchased from Sigma. Control cells, as well as cells treated with H 2 O 2 , were lysed using a Triton X-100 based lysis buffer (1% Triton X-100, 10% glycerol, 150 mM NaCl, 20 mM Tris (pH 7.5), 2 mM EDTA) in the presence of a protease inhibitor mix (Roche Applied Science). Approximately 20 μg of whole cell extract was mixed with 2× SDS-sample buffer and boiled for 5 min. The samples were resolved on SDS-PAGE and electro-transferred onto polyvinylidene difluoride (PVDF) membranes (Thermo Scientific) using a semi-dry cell transfer blot (Bio-Rad). 4% nonfat dry milk in TBST buffer (25 mM Tris-HCl, pH 8.0, 125 mM NaCl, 0.1% Tween 20) was used to block nonspecific binding of the membrane. The membrane was incubated with the indicated primary antibodies followed by the specific secondary peroxidase-conjugated antibodies. The membrane was visualized by enhanced chemiluminescence (ECL) (Thermo Scientific).
Subcellular fractionation and apoptotic assay
HK-2 (human kidney 2) cells were grown in 150 mm dishes. When the cells reached 90% confluence, they were treated with H 2 O 2 (200 μM) or etoposide (125 μM) for 10 h. After this time, the cells were detached using trypsin-EDTA (Invitrogen), washed twice with ice-cold phosphate-buffered saline and processed for fractionation using the commercially available Mitochondria Isolation Kit (Thermo Scientific) according to the manufacturer's instructions. Briefly, the homogenized cells were centrifuged at 700 ×g for 10 min and the pellet representing the crude nuclear fraction was discarded. The supernatant was collected and centrifuged at 3000 ×g for 15 min. Both the resultant pellet, representing the mitochondrial fraction, and the supernatant cytosolic fractions were collected. The fractions were analyzed by SDS-PAGE and Western blot using the following antibodies: Mulan, Omi/HtrA2, cytochrome c, and β-actin. A fraction of the treated cells was used for cell death assay; the cells were resuspended in 1× binding buffer and stained with Annexin V and 7-AAD according to BD Biosciences protocol, followed by analysis on a FACSCalibur flow cytometer. Cell death in the population was estimated using Annexin V (early apoptosis) and 7-aminoactinomycin D (late apoptosis) [22, 34, 35 ].
In vitro degradation assay
The ability of recombinant His-Omi 134-458 protease to cleave Mulan in vitro was investigated. For this experiment, the inter-membrane domain (IMD) of the Mulan protein corresponding to amino acids 30-240 (His-Mulan ) and the cytoplasmic domain (CD) corresponding to amino acids 245-352 (His-Mulan 245-352 ) were cloned in frame in the pET-28a bacteria expression vector (Novagen). Recombinant proteins His-Mulan and His-Mulan 245-352 were purified on nickel-nitrilotriacetic acid (Ni-NTA) affinity resin as previously described [36] . His-Omi 134-458 (400 ng) or His-Omi-S/A 134-458 (encoding the inactive protease) was incubated with 400 ng of His-Mulan or His-Mulan 245-352 in 15 μl reaction volume in the assay buffer (20 mM Na 2 HPO 4 (pH 8), 10% glycerol, 200 mM NaCl). After 20, 40, and 60 min of incubation at 37°C, the reactions were stopped with the addition of 2× SDS-sample buffer. Reaction products were analyzed by SDS-PAGE followed by Coomassie Blue staining.
Expression of Mulan and Omi/HtrA2 proteins in various tissues derived from mnd2 mutant mice
Mouse tissues were prepared as described [36] . In short, tissue samples were taken from 25-day old mnd2 mutant mice as well as their wild type littermates and immediately placed in ice-cold lysis buffer containing 150 mM NaCl, 20 mM Tris·HCl, pH 7.6, 1 mM CaCl 2 , 1 mM MgCl 2 , 10% glycerol, 1% Nonidet P-40, 5 mM NEM (N-Ethylmaleimide), and complete protease mixture tablets (Roche). Tissues were homogenized with an Ultra-Turrax T8 (IKA-werke). Protein concentration was determined using the Bio-Rad protein assay. Approximately 20-50 μg of whole cell extract was used for SDS-PAGE followed by Western blot analysis.
2.6. Expression of Mulan, Omi/HtrA2, and Mfn2 proteins in cells treated with various stress-inducing chemicals HK-2 cells were grown in six-well plates in the appropriate media until they reached 80% confluence; they were then treated for 10 h with one of the following: cisplatin (40 μM), etoposide (125 μM), H 2 O 2 (200 μM), antimycin (10 μM), or antimycin (10 μM). Cells were also treated with Paraquat (300 μM) for 12 h. After this time, cells were detached, washed twice with ice-cold phosphate-buffered saline (PBS), and re-suspended in lysis buffer for Western blot analysis. Measurement of mitochondrial reactive oxygen species (ROS) and cell death was assessed as previously described [32, 37, 38] . Briefly, after the various treatments cells were detached by trypsinization, washed, and stained either for 30 min at 37°C with 5 μM of MitoSOX red or with Annexin V and 7-AAD for 20 min at room temperature. After this time cells were washed twice with HBSS and analyzed by FACScalibur.
Ectopic expression of Omi-GFP or Omi-S/A-GFP
HEK293 (human embryonic kidney) cell line was used for transfection experiments. Cells were grown in six-well plates and transfected with GFP-N1, Omi-GFP, or Omi-S/A-GFP (encodes the inactive protease) plasmids using Lipofectamine 2000 (Invitrogen). Eighteen hours after transfection, cells were treated with etoposide (125 μM) or with H 2 O 2 (200 μM) for 10 h. Cell extracts were prepared and analyzed by Western blot using specific antibodies.
Relative abundance of mitochondria in Omi/HtrA2(−/−), Omi/HtrA2(+/+), and Omi-S/A MEFs
The relative abundance of mitochondria in Omi/HtrA2(−/−), Omi/HtrA2(+/+), and Omi-S/A MEFs was monitored as previously described [39, 40] . Briefly, equal numbers of MEFs were grown in 12-well plates for 12 h and then washed with PBS, trypsinized, re-suspended in the appropriate buffer and stained with MitoTracker Red 580 (100 nM; Molecular Probes) for 30 min at 37°C. The cells were then washed and analyzed by FACSCalibur (BD Biosciences). CellQuest analysis software (BD Biosciences) was used for data analysis.
Confocal microscopy
Equal numbers of Omi/HtrA2(+/+) and (−/−) MEFs were seeded on glass coverslips in 12-well plates. Twelve hours later they were placed in a medium containing GFP-LC3 adenovirus (kindly provided by Dr. Gustafsson) [41] [42] [43] . After 24 h of incubation, cells were loaded with MitoTracker Red and treated with CCCP (20 μM) or DMSO control for 4 h. Cells were washed, fixed with 4% paraformaldehyde for 15 min and mounted in a glass slide. Cells were examined using a LSM 710 confocal microscope, and analyzed using ZEN lite software (Carl Zeiss). To assess the degree of autophagy, GFP-LC3 fluorescence was examined at 63 × magnification and cells were classified as having diffuse GFP-LC3 fluorescence or as cells with N10 GFP-LC3 puncta/cell. For the quantification of autophagosomes in single cells, at least 50 representative cells per condition in three separate experiments were acquired, and the number of autophagosomes in each cell was counted. In addition, we used LysoTracker Red (LTR) and MitoTracker Green (MTG) to assess mitophagy, where depolarized mitochondria co-localize with autophagosomes. LTR is an acidotropic fluorescent probe used to label and track acidic organelles in living cells including lysosomes and autophagosomes [44] [45] [46] . Omi/HtrA2(+/+) and Omi/HtrA2(−/−) MEFs were treated with 20 μM CCCP or DMSO (control) and loaded with LTR (200 mM) and MTG (200 nM) for 2 h. Cells were washed, fixed with 4% paraformaldehyde and mounted in a glass slide. Confocal microscopy was used to monitor fluorescence which was examined at 100× magnification.
Statistical analysis
All quantitative data is expressed as mean ± SD of three or five independent experiments. Following Western blot analysis, Mulan/GAPDH or Mulan/β-actin ratios were obtained from the densitometry data using a Bio-Rad Chemidoc XRS imaging system and analyzed by Quantity One software. Differences among groups were analyzed by one-way ANOVA followed by Tukey-Kramer method using StatPlus software. A value of P b 0.05 was considered significant.
Results

Omi/HtrA2 protease regulates the protein levels of Mulan under normal conditions as well as in response to oxidative stress
Omi/HtrA2 is a serine protease that under normal conditions is present exclusively in the IMS of the mitochondria. Mulan E3 ubiquitin ligase is anchored in the OMM. It has two trans-membrane regions separated by 210 amino acids that create a large IMS domain ( Fig. 1A) . Furthermore, Mulan's RING-finger domain facing the cytosol has extensive amino acid similarity to the corresponding domain of the Inhibitor of Apoptosis Proteins (IAPs), which are known substrates of the Omi/HtrA2 protease; however, the biological significance of this homology is unclear [28] . March5 and RNF185 are transmembrane proteins that cross the OMM four and two times, respectively. They are the only other two known mitochondrial E3 ubiquitin ligases that have their RING-finger domain exposed to the cytoplasm (Fig. 1A ) [27, 28, [47] [48] [49] . We determined the protein levels of Mulan, March5, and RNF185 in whole cell lysates prepared from Omi/HtrA2(−/−) as well as Omi/HtrA2(+/+) MEFs. While no significant difference was observed in the level of March5 or RNF185, a substantial increase in Mulan protein level was observed in Omi/HtrA2(−/−) compared to Omi/HtrA2(+/+) MEFs (Fig. 1B) . This result suggests that Mulan could be a potential substrate of Omi/HtrA2. We further investigated whether the proteolytic activity of Omi/HtrA2 is required for Mulan regulation especially under conditions of oxidative stress. For these experiments, we used Omi/HtrA2(−/−) MEF as well as Omi/HtrA2(−/−) MEF cells where Omi/HtrA2 activity has been rescued by stable transfection of Omi/HtrA2 wild type gene, Omi/HtrA2(+/+), or an Omi/HtrA2 mutant form Omi/HtrA2-S/A. Omi/HtrA2-S/A carries an amino acid substitution (Ser306Ala) that completely abolishes the proteolytic activity of the enzyme [10] . Fig. 1C shows that the basic expression of Mulan protein was much higher in Omi/HtrA2(−/−) and Omi/HtrA2-S/A compared to that in Omi/HtrA2(+/+) MEFs. In addition, treatment with hydrogen peroxide (H 2 O 2 ) resulted in a notable reduction of Mulan protein level in Omi/ HtrA2(+/+) MEFs. However, in Omi/HtrA2(−/−) or Omi/HtrA2-S/A MEFs, H 2 O 2 had no detectable effect (Fig. 1C) . These results indicate that the down-regulation of Mulan protein by oxidative stress requires the presence of an active Omi/HtrA2 protease. The same blot was also probed for Omi/HtrA2 protein expression in the three cell lines used. As expected, in the Omi/HtrA2(−/−) MEFs there is complete absence of Omi/HtrA2 protein expression, and H 2 O 2 treatment did not affect the levels of wild type or Omi/HtrA2-S/A protein in the corresponding cell lines.
Next, we tested whether the cleavage and the degradation of Mulan following H 2 O 2 treatment occur in the mitochondria or the cytoplasm. Since H 2 O 2 induces cell death, we investigated whether cleavage of Mulan is a result of the pro-apoptotic function of Omi/HtrA2 in the cytoplasm. For this experiment, cells were treated with H 2 O 2 or etoposide. Mitochondrial and cytoplasmic fractions were prepared, and the protein levels of Mulan and Omi/HtrA2 were analyzed by SDS-PAGE and Western blot using specific antibodies. Cytochrome c and β-actin were also used as controls. Fig. 1D shows that Mulan is exclusively present in the mitochondria, and its protein level was significantly reduced after the cells were treated with H 2 O 2 , whereas etoposide treatment had no detectable effect. Under these conditions, H 2 O 2 and etoposide treatments induced about 40% apoptosis in the cell population (Fig. 1E) , and both caused the release of Omi/HtrA2 and cytochrome c into the cytoplasm. These experiments suggest that the specific degradation of Mulan protein during H 2 O 2 treatment occurs while Omi/HtrA2 is confined in the mitochondria and is not part of the pro-apoptotic pathway. The small amount of Omi/HtrA2 proteins present in the cytoplasm of control (untreated) cells is due to a slight cross contamination between these two fractions.
Mulan 30-240 is cleaved by Omi/HtrA2 protease in vitro
We tested whether Mulan protein could be a substrate of Omi/HtrA2 protease in vitro and, if so, to identify which domain of Mulan, intermembrane domain (IMD) and/or cytoplasmic domain (CD), is cleaved. For this experiment, the IMD of Mulan ( Fig. 2A) corresponding to amino acids 30-240 (His-Mulan ), as well as Mulan CD, amino acids 245-352 (His-Mulan 245-352 ) were cloned, expressed in bacteria, and purified as described in the Materials and methods section. His-Mulan was incubated with His-Omi/HtrA2 134-458 protease for different time periods. Fig. 2B shows that His-Omi/HtrA2 134-458 was able to degrade the Mulan IMD in this assay. To verify if the cleavage of Mulan was due to Omi/HtrA2 activity and not to some other contaminating bacterial protease, we used an inactive His-Omi/HtrA2-S/ A 134-458 protease. This enzyme has the Serine 306 replaced with an Alanine, which completely abolishes its protease activity [10, 11] . When used in this assay, His-Omi/HtrA2-S/A 134-458 was not able to degrade His-Mulan (Fig. 2C ). When the CD His-Mulan 245-352 was tested in the same in vitro assay, it was not cleaved by His-Omi/HtrA2 134-458 (Fig. 2D) . The activity of the recombinant His-Omi/HtrA2 134-458 protease was verified using β-casein as a generic substrate (Fig. 2D ).
Expression of Mulan and Omi/HtrA2 proteins in various tissues of mnd2 mutant mice
Mnd2 mutant mice carry a single missense mutation (Ser276Cys) in the Omi/HtrA2 gene [15] . This mutation inactivates the protease activity of Omi/HtrA2. derived from mnd2 mutant mice or their wild type littermates. Mulan protein levels are substantially higher in the heart, spleen, and kidney tissues, as well as in the cortex and the striatum of mnd2 mice that do not have a functional Omi/HtrA2 protease. All of these organs from mnd2 mutant mice show clear morphological defects. Furthermore, excessive neuronal cell death in the striatum has been implicated in the neurodegenerative disorder and the early death of these mutant animals [15] .
3.4. Regulation of Mulan, Omi/HtrA2, and Mfn2 proteins in HK-2 cells treated with various stress-inducing chemicals HK-2 cells were treated with various chemicals including: cisplatin, etoposide, H 2 O 2 , antimycin and paraquat. Fig. 4A clearly shows that H 2 O 2 is the only treatment able to induce significant reduction in Mulan protein level under these conditions. There was no detectable change in the protein level of Omi/HtrA2 under any of these conditions (Fig. 4A ). We also monitored the level of Mfn2 protein, a known substrate of Mulan, and a protein involved in mitochondrial fusion. As expected there is an inverse correlation between the protein levels of Mulan and Mfn2. To verify that the chemical treatments were detrimental to the cells, we monitored the percentage of cell death for each treatment (Fig. 4B) as well as the relative amount of mitochondrial ROS (reactive oxygen species) produced using MitoSOX staining (Fig. 4C ). H 2 O 2 , antimycin and paraquat produced the highest levels of ROS and cell death ( Fig. 4A and B) . A time course of Mulan degradation following treatment with H 2 O 2 is shown in Fig. 4D . Mulan degradation was detectable after 8 h and there was no change in Omi/HtrA2 protein levels throughout the time period of the experiment. Fig. 4E shows the percentage of apoptotic cells in the population over the 14 h period.
Effect of Omi-GFP or Omi-S/A-GFP overexpression on endogenous Mulan protein levels
We investigated whether overexpression of Omi/HtrA2 in HEK293 cells will affect the protein levels of Mulan further supporting the idea that Mulan is a physiological substrate of Omi/HtrA2 in vivo. For these experiments, we transfected HEK293 cells with Omi-GFP or the inactive form Omi-S/A-GFP. Omi-GFP is processed by auto-cleavage to form mature Omi (aa134-458). This form of Omi/HtrA2 runs a little bit higher than the endogenous Omi/HtrA2 due to the presence of an epitope tag. The inactive protease Omi-S/A-GFP cannot be processed by autocleavage to form the mature Omi/HtrA2. Fig. 4F shows that cells transfected with Omi-GFP and treated with H 2 O 2 show significant Mulan degradation due to the increased protein level of Omi/HtrA2. In contrast, over-expression of the inactive form of Omi-S/A-GFP had no effect and competed with the endogenous Omi/HtrA2 protease to partially block Mulan degradation. All these data indicate that Omi/HtrA2 is solely responsible for regulating Mulan protein levels. HEK293 cells were used for this transfection experiments since, unlike HK-2 or MEFs, they can be transfected with very high efficiency. Etoposide treatment has no effect on Mulan protein levels and was used here as a negative control.
Assessment of the mitochondria abundance in Omi/HtrA2(−/−), Omi/HtrA2(+/+), and Omi-S/A MEFs and regulation of Mulan by CCCP treatment
Mulan E3 ligase has been previously shown to be involved in mitophagy [30] . Mitochondrial dysfunction and increased autophagy/ mitophagy have also been reported in the absence of Omi/HtrA2 protease activity [17] . We investigated the relative abundance of healthy mitochondria present in Omi/HtrA2(−/−) compared to Omi/HtrA2(+/+) or Omi/HtrA2-S/A MEFs. For these experiments, MEFs were stained with MitoTracker Red and analyzed by flow cytometry. The histogram in Fig. 5A shows that Omi/HtrA2(+/+) MEFs have more healthy mitochondria as seen by the higher intensity of MitoTracker-Red staining compared to Omi/HtrA2(−/−) or Omi/HtrA2-S/A MEFs. Furthermore, we investigated if Mulan protein levels were affected differently by CCCP treatment in the absence of Omi/HtrA2 protease. CCCP is a mitochondrial uncoupler and an inducer of mitophagy [50] . For these experiments, Omi/HtrA2(−/−), Omi/HtrA2(+/+), and Omi/HtrA2-S/A MEFs were treated with CCCP, and the Mulan protein levels were analyzed by Western blotting. Fig. 5B shows that CCCP treatment increases the protein level of Mulan in all three cell-lines. However, there is significantly more accumulation of Mulan protein in the two MEFs that either lack Omi/HtrA2 or have the inactive Omi/HtrA2-S/A protease. These results show a clear correlation between the absence of Omi/HtrA2 protease and accumulation of Mulan following CCCP treatment, and are consistent with our hypothesis that high levels of Mulan protein invariably lead to increased mitophagy.
3.7. Assessment of mitophagy in Omi/HtrA2(+/+) and Omi/HtrA2(−/−) MEFs using confocal microscopy
We compared the degree of mitophagy between the Omi/ HtrA2(+/+) and Omi/HtrA2(−/−) MEFs following treatment with the mitochondrial uncoupler CCCP [50] [51] [52] [53] . For these experiments, cells were infected with GFP-LC3 expressing adenovirus, treated with CCCP, and loaded with MitoTracker Red 580 that accumulates in the mitochondria with an intact membrane potential. In the absence of CCCP treatment, GFP-LC3 is diffusely distributed throughout the cytoplasm in both Omi/HtrA2(+/+) and Omi/HtrA2(−/−) MEFs (Fig. 6A top  panels) . After CCCP treatment, a large number of GFP-LC3-positive aggregates (autophagosomes) appear in the Omi/HtrA2(−/−) cells compared to only a few present in the Omi/HtrA2(+/+) MEFs (Fig. 6A ). Many of these GFP-LC3-positive autophagosomes co-localize with red fluorescence-labeled mitochondria (yellow dots indicated by arrows). For a more quantitative analysis of the mitophagy in Omi/ HtrA2(+/+) and Omi/HtrA2(−/−) MEFs, random images of cells with or without CCCP treatment were captured and analyzed. A minimum of 50 cells per condition per experiment were analyzed and classified as: (a) cells with diffuse GFP-LC3 fluorescence (untreated/control), or as (b) cells with numerous GFP-LC3 puncta (N10dots/cell) representing autophagosomes. Omi/HtrA2(+/+) MEFs show significantly less GFP-LC3 puncta compared to the Omi/HtrA2(−/−) MEFs (Fig. 6B ). autophagosomes [45, 46] . Omi/HtrA2(+/+) and Omi/HtrA2(−/−) MEFs were treated with 20 μM CCCP or DMSO (control) for 4 h and loaded with LTR and MTG for 2 h. Confocal microscopy was used to examine cells. Fig. 7A shows that Omi/HtrA2(−/−) MEFs have more LTR-labeled organelles per cell compared to Omi/HtrA2(+/+) cells. This difference becomes even more pronounced after CCCP treatment. There is also extensive co-localization of MTG-stained mitochondria and LTR-stained autophagosomes (yellow spots). Omi/HtrA2(+/+) MEFs show significantly less LTR puncta per cell compared to the Omi/HtrA2(−/−) MEFs (Fig. 7B ).
3.9. Deregulation of Mulan affects the protein level of Mfn2 protein in the heart of mnd2 mutant mice
We investigated whether the up-regulation of Mulan that is observed in the absence of Omi/HtrA2 protease directly affects its downstream targets. There are several known substrates of Mulan E3 ubiquitin ligase including NF-κΒ, JNK, p53, Akt, and Mfn2 [28] [29] [30] 54] . In terms of mitochondrial function, the most relevant substrate is the Mfn2, a protein involved in mitochondrial fusion that is down-regulated during mitophagy [55, 56] . Mfn2 is ubiquitinated by Mulan and is targeted for proteasome-induced degradation [30] . Furthermore, it has been previously shown that Mfn2 is regulated by Mulan in the skeletal muscles and also plays an important role in the heart [30] . We investigated whether the Mulan deregulation that occurs in the absence of Omi/HtrA2 can affect Mfn2 protein. We used heart tissues where Mfn2 protein is fairly abundant and easily detected. Fig. 8A shows the respective protein levels of Mulan and Mfn2 in heart tissues derived from mnd2 mutant mice (−/−) as well as their wild type littermates (+/+). There is an inverse correlation between the protein levels of Mulan and Mfn2. Mnd2 mutant mice have higher levels of Mulan protein (also shown in Fig. 3A ) but significantly reduced levels of Mfn2 protein compared to the protein levels of the wild type animals. The Omi/HtrA2 protein levels are very similar, although the mnd2 mutant animals carry the mutated form of the gene (Ser276Cys) that lacks detectable proteolytic activity.
Discussion
Most studies about Omi/HtrA2 have focused on its role as a proapoptotic protein when it is released from the mitochondria during apoptosis, but the main function of Omi/HtrA2 within the mitochondria is cytoprotective, and the mechanism still remains controversial [6, 16, 17, [57] [58] [59] . A pro-survival role for Omi/HtrA2 in the mitochondria is supported by the link between the loss of Omi/HtrA2 and neurodegenerative diseases. The mnd2 mutant mice have lost the activity of Omi/HtrA2 protease as a result of a missense mutation (Ser276Cys), and invariably develop multiple organ defects including a neurodegenerative phenotype with parkinsonian features [15] . Furthermore, mutations in Omi/HtrA2 have been reported in PD patients [18] [19] [20] [60] [61] [62] although other studies have contradicted those findings [63] . Omi/HtrA2's bacterial homolog DegP is a known chaperone at normal temperatures, and is used to remove denatured and unfolded proteins at elevated temperatures [17, 64, 65] . Thus far, the function of Omi/HtrA2 in the mitochondria has been defined by its interaction with PINK and rhomboid-7 proteins [17, 66] . The function of this interaction was proposed to be the post-translational modification of Omi/HtrA2 and the subsequent regulation of its protease activity [62, 67] . In addition, mitochondrial Omi/HtrA2 has been shown to cleave the anti-apoptotic protein Hax-1, degrade Parkin, and associate with γ-secretase, Parl (presenilin-associated, rhomboid-like), and mitochondrial fusion factor OPA1 [21] [22] [23] [24] [25] . Under normal conditions, Omi/HtrA2 is found exclusively in the IMS. Therefore, we investigated whether Omi/HtrA2 can potentially regulate protein(s) that have a function in UPS but are also present in the IMS. We identified the mitochondrial Mulan E3 ligase to be directly controlled by Omi/HtrA2. The RING-finger domain of Mulan has amino acid similarity with the corresponding domain of the Inhibitor of Apoptosis Proteins (IAPs), which are known cytoplasmic substrates of Omi/HtrA2 [28, 68] . The biological significance of this homology is unclear. Our data indicate that the inter-membrane domain (IMD), but not the cytoplasmic domain (CD) of Mulan can be degraded by Omi/HtrA2 in vitro. Mulan protein levels are also regulated by Omi/HtrA2 in vivo and accumulate in MEFs that lack Omi/HtrA2. Accumulation of Mulan protein in Omi/HtrA2(−/−) MEFs can be prevented by expressing the wild type Omi/HtrA2, but not the mutant form of Omi/ HtrA2-S/A that lacks proteolytic activity. Of course, we cannot exclude the possibility that Mulan is cleaved in vivo by a different protease that is regulated in the presence of Omi/HtrA2. Deregulation of Mulan is also seen in mnd2 mutant mice that lack an active Omi/HtrA2 protease, resulting in Mulan protein accumulation in various tissues of these animals. The regulation of Mulan is specific; March5 and RNF185, the other two known mitochondrial E3 ubiquitin ligases with similar topology to Mulan, are not affected by Omi/HtrA2 protease. Furthermore, during H 2 O 2 Mulan is degraded and removed only in cells that have an active Omi/HtrA2 protease. Since H 2 O 2 causes the release of Omi/HtrA2 from the mitochondria and induces cell death, we investigated whether degradation of Mulan might be part of the pro-apoptotic function of Omi/ HtrA2 in the cytoplasm. Etoposide was used to induce cell death, which is also associated with release of Omi/HtrA2 to the cytoplasm. In contrast to H 2 O 2 , treatment with etoposide had no detectable effect on the level of Mulan. These data strongly suggests that degradation of Mulan targets its IMD and occurs while Omi/HtrA2 is confined in the mitochondria. In addition to etoposide, several other chemical treatments that induce cellular stress were used including cisplatin, antimycin, and paraquat. All these treatments produced various levels of mitochondrial ROS and cell death. None of them affected the level of Mulan protein. Mulan protein levels had an inverse correlation with Mfn2 protein, a known substrate of this E3 ligase that participates in mitochondrial fusion [30] . Whether mitochondria. Alternatively, H 2 O 2 could act on the substratein this case the IMD of Mulanand by changing its conformation make it more susceptible to proteolysis. We investigated whether mitophagy might be affected in the absence of Omi/HtrA2 and the accumulation of Mulan. Our experiments showed that Omi/HtrA2(+/+) MEFs have more healthy mitochondria than Omi/HtrA2(−/−) or Omi/HtrA2-S/A cells. Increased mitophagy/autophagy has also been reported in cells lacking active Omi/HtrA2 protease [17] . In addition, up-regulation of Mulan through transcriptional activation is known to increase mitophagy [30] . Omi/ HtrA2(−/−) MEFs showed increased mitophagy compared to wild type Omi/HtrA2(+/+) cells. Mitophagy became more pronounced when cells were treated with CCCP. Furthermore, Omi/HtrA2(−/−) MEFs have more autophagosomes that co-localize with mitochondria than Omi/HtrA2(+/+) cells, both under normal conditions and after CCCP treatment. CCCP treatment induced Mulan protein that accumulated at much higher levels in Omi/HtrA2(−/−) or Omi/HtrA2-S/A than in Omi/HtrA2(+/+) MEFs. Omi/HtrA2(−/−) MEFs contained a larger number of autophagosomes and showed increased mitophagy than Omi/HtrA2(+/+) cells. We further investigated whether the accumulation of Mulan protein is actively involved in the process leading to increased mitophagy in Omi/HtrA2(−/−) MEFs. We monitored the protein level of Mfn2, a large GTPase and a known substrate of Mulan. Mfn2 is essential for mitochondrial fusion and it is down-regulated during mitophagy [69] [70] [71] . Mulan directly ubiquitinates Mfn2, which targets this protein for proteasomal degradation [30] . Conditional deletion of Mfn2 in heart and skeletal muscles causes mitochondrial dysfunction, cardiac hypertrophy, and muscle wasting [30, 72, 73] . Similar muscle and heart phenotypes are also observed in mice lacking Omi/HtrA2 in non-neuronal tissues [17] . Our results showed that the up-regulation of Mulan, in the absence of Omi/HtrA2, leads to the degradation and removal of Mfn2 in the heart of the mnd2 mice. Our data clearly shows that Omi/HtrA2 regulates Mulan protein levels and deregulation of this pathway leads to increased mitophagy. It is also possible that this pathway might be involved in other biological events besides mitophagy, or might have a different function in various tissues. The function of Mulan in the mitochondria under normal conditions or during oxidative stress is unclear. Its unique topology allows the protein to communicate signals from within mitochondria to the cytoplasm. Its regulation by Omi/HtrA2 suggests that the relative protein levels of Mulan are important for its function. Our results showed that its over-expression leads to degradation of Mfn2 and possibly other substrates present in the OMM or the cytoplasm. Mfn2 is predominantly expressed in the heart and skeletal muscles where it is probably the main substrate of Mulan. Our recent studies suggest that Mulan can interact with at least four different E2 ubiquitin conjugating enzymes, and each unique Mulan/E2 complex can recognize different substrates (Ambivero et al., in preparation).
In summary, we have identified a new mitochondrial pathway that involves the regulation of Mulan E3 ubiquitin ligase by Omi/HtrA2 protease under normal conditions, after H 2 O 2 exposure, or during CCCP treatment. Inactivation of Omi/HtrA2 protease mimics mitochondrial uncoupling since both lead to accumulation of Mulan. Mitochondrial uncoupling has been previously implicated in the neurodegeneration observed in the Omi/HtrA2 KO mice [74] . Mulan, like Parkin, is an E3 ubiquitin ligase, but the role of Parkin in mitophagy has been extensively studied [75] . There are also reports of Parkin-independent mitophagy though the mechanism remains unknown [76] . The pathway described here involving Mulan and its regulation by Omi/HtrA2 could be an alternative mechanism to Parkin-induced mitophagy. In support of this notion, loss of Omi/HtrA2 has been shown to have no affect on the Parkin/Pink pathway [77] . In another study, Drosophila Omi/HtrA2 was found to act downstream of Pink1 and independently of Parkin [78] . We expect that the accumulation of Mulan in the absence of Omi/HtrA2 mimics mitochondrial uncoupling and activates mitophagy of healthy mitochondria. This causes an imbalance in mitochondrial numbers and affects primarily cells with high-energy requirements, such as neurons, cardiomyocytes, and muscle cells which begin to die. We expect that this process is responsible for the phenotype observed in the mnd2 mutant mice, which includes neurodegeneration, and a plethora of other defects such as dilated cardiomyopathy and muscle atrophy. It would be of interest to investigate whether mutations in Mulan E3 ubiquitin ligase could be found in patients with neurodegenerative disorders or cardiomyopathies.
